文献速递耳科与耳神经

高压氧联合药物治疗与单纯药物治疗突发性聋的系统评价与荟萃分析

Addition of Hyperbaric Oxygen Therapy vs Medical Therapy Alone for Idiopathic Sudden Sensorineural Hearing Loss: A Systematic Review and Meta-analysis.
PubMed 文献 · JAMA Otolaryngol Head Neck Surg · 2018-01-01

该系统评价与荟萃分析比较高压氧联合药物治疗与单纯药物治疗对突发性感音神经性聋的疗效,纳入3项随机临床试验和16项非随机研究共2401例患者,发现联合治疗组完全恢复和部分恢复的合并比值比均显著更高,绝对听力增益也更优,基线重度至极重度听力损失、挽救性治疗及总高压氧时长至少1200分钟者获益更大。

要点

  • 高压氧联合药物治疗可显著提高突发性聋的完全恢复和部分恢复率。
  • 基线重度至极重度听力损失者及挽救性治疗者从高压氧联合治疗中获益更大。
  • 总高压氧时长至少1200分钟时获益更明显。

核心结论

  • 在标准药物治疗基础上加用高压氧是突发性感音神经性聋的合理治疗选择。
  • 基线重度至极重度听力损失及接受挽救性治疗且疗程较长者获益更明显。

研究设计与样本

  • 系统评价与荟萃分析,检索PubMed、Embase和Cochrane系统评价数据库至2018年2月。
  • 纳入3项随机临床试验和16项非随机研究,共2401例突发性感音神经性聋患者,平均年龄45.4岁,女性占55.3%。
  • 采用随机效应模型进行荟萃分析。

主要发现

  • 高压氧联合药物组完全听力恢复的合并比值比为1.61(95%CI 1.05-2.44),显著高于单纯药物组。
  • 高压氧联合药物组部分听力恢复的合并比值比为1.43(95%CI 1.20-1.67),显著高于单纯药物组。
  • 高压氧联合药物组的绝对听力增益显著大于单纯药物组。
  • 基线重度至极重度听力损失、高压氧作为挽救性治疗及总高压氧时长至少1200分钟者,高压氧获益更大。

关键数值与推荐

  • 主要结局为完全听力恢复,次要结局为部分听力恢复和绝对听力增益。
  • 完全听力恢复OR 1.61(95%CI 1.05-2.44);部分听力恢复OR 1.43(95%CI 1.20-1.67)。
  • 总高压氧时长至少1200分钟时获益更明显。

临床怎么用

  • 对突发性感音神经性聋患者,可考虑在标准药物治疗基础上加用高压氧。
  • 尤其对基线重度至极重度听力损失及挽救性治疗患者,可考虑较长疗程的高压氧(总时长至少1200分钟)。
  • 应制定合适的患者选择标准和标准化高压氧方案用于常规实践。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Sudden sensorineural hearing loss (SSNHL) causes substantial disease burden for both individuals and socioeconomic aspects. The benefit of hyperbaric oxygen therapy (HBOT) in addition to standard medical therapy (MT) for idiopathic SSNHL has been unclear. OBJECTIVE: To perform a systematic review and meta-analysis to compare HBOT + MT with MT alone as a treatment for patients with SSNHL. DATA SOURCES: PubMed, Embase, and the Cochrane Database of Systematic Reviews were systematically searched up to February 2018. STUDY SELECTION: Randomized clinical trials and nonrandomized studies comparing HBOT + MT with MT alone for SSNHL treatment. DATA EXTRACTION AND SYNTHESIS: Two investigators independently screened the eligible studies, established data, and assessed quality and risk of bias. A systematic review and meta-analysis using random-effects models was conducted. MAIN OUTCOMES AND MEASURES: The primary outcome was complete hearing recovery, and secondary outcomes were any hearing recovery and absolute hearing gain. RESULTS: Three randomized clinical trials and 16 nonrandomized studies comparing outcomes after HBOT + MT vs MT alone in 2401 patients with SSNHL (mean age, 45.4 years; 55.3% female) were included. Pooled odds ratios (ORs) for complete hearing recovery and any hearing recovery were significantly higher in the HBOT + MT group than in the MT alone group (complete hearing recovery OR, 1.61; 95% CI, 1.05-2.44 and any hearing recovery OR, 1.43; 95% CI, 1.20-1.67). Absolute hearing gain was also significantly greater in the HBOT + MT group than in the MT alone group. The benefit of HBOT was greater in groups with severe to profound hearing loss at baseline, HBOT as a salvage treatment, and a total HBOT duration of at least 1200 minutes. CONCLUSIONS AND RELEVANCE: The addition of HBOT to standard MT is a reasonable treatment option for SSNHL, particularly for those patients with severe to profound hearing loss at baseline and those who undergo HBOT as a salvage treatment with a prolonged duration. Optimal criteria for patient selection and a standardized regimen for HBOT should be applied in routine practice, with future trials to investigate maximal treatment benefit.

来源:JAMA Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Rhee TM, Hwang D, Lee JS, et al. Addition of Hyperbaric Oxygen Therapy vs Medical Therapy Alone for Idiopathic Sudden Sensorineural Hearing Loss: A Systematic Review and Meta-analysis. JAMA Otolaryngol Head Neck Surg. 2018. PMID: 30267033. doi:10.1001/jamaoto.2018.2133

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。